New concepts in anorexia nervosa

Journal of Pediatric Endocrinology and Metabolism

Volumn 17, Issue SUPPL. 3, 2004, Pages 473-480

  Munoz M T ^a   Argente, Jesús ^a  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

Author keywords

Anorexia nervosa; Appetite; Bone mineral density; Ghrelin; Growth hormone; Hypogonadotropic hypogonadism; IGFBPs; Leptin; Neuropeptide Y

Indexed keywords

CALCIUM; ESTROGEN; FOLLITROPIN; GHRELIN; GROWTH HORMONE; LEPTIN; LUTEINIZING HORMONE; NEUROPEPTIDE Y; PROGESTERONE; RECOMBINANT SOMATOMEDIN C; SEROTONIN; SOMATOMEDIN BINDING PROTEIN; VITAMIN D;

AMENORRHEA; ANOREXIA NERVOSA; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE REMODELING; DELAYED PUBERTY; DISEASE ASSOCIATION; ENERGY BALANCE; EXERCISE; HUMAN; HYPERCORTISOLISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; HYPOTHYROIDISM; OLIGOMENORRHEA; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL ACTIVITY; PSYCHOSOMATIC DISORDER; REGULATORY MECHANISM; WEIGHT REDUCTION;

ANOREXIA NERVOSA; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM;

EID: 17144437999     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: American Psychiatric Association, 1994.
2. Perez-Gaspar M, Gual P, de Irala-Estevez J, Martínez-Gonzalez MA, Lahortiga F, Cervera S. Prevalencia de los trastornos de la conducta alimentaria en los adolescentes navarros. Medicina Clinica 2000; 114: 481-486.
3. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-671.
4. Kaye WH, Berrettini NH, Gwirstman HE, Gold PW, Jimerson DC, Ebert MH. Contribution of CNS neuropeptide (NPY, CRH, and beta-endorphin) alterations to psychophysiological abnormalities in anorexia nervosa. Psychopharmacol Bull 1989; 25: 433-438.
5. Rogol AD. Leptin and puberty. J Clin Endocrinol Metabol 1998; 83: 1089-1090.
6. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide frorn stornach. Nature 1999; 402: 656-660.
7. Shiiya T, Nakazato M, Mizuta M. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-244.
8. Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL. A receptor subtype involved in neuropeptide-Y induced food intake. Nature 1996; 382: 168-171.
9. 2A promoter polymorphism - 1438 G/A, anorexia nervosa, and obsessive-compulsive disorder. Lancet 1998; 351: 1785-1786.
10. 2A receptor gene polymorphism in anorexia nervosa and bulimia nervosa. Neurosci Lett 1999; 277: 134-136.
11. Couzinet B, Young J, Brailly S, Le Buc Y, Chanson P, Schaison G. Functional hypothalamic amenorrhea: a partial and reversible gonadotrophin deficiency of nutritional origin. Clin Endocrinol 1999; 50: 229-235.
12. Muñoz MT, Morandé G, Argente J. Anomalías en el patron de secreción de gonadotropinas en las pacientes adolescentes afectadas de anorexia nerviosa. Endocrinología 1997; 44: 248-252.
13. Baranowska B. Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa? Psychoneuroendocrinology 1990; 15: 371-379.
14. Hileman SM, Pierroz DD, Flier JS. Leptin, nutrition, and reproduction: timing is everything. J Clin Endocrinol Metab 2000; 85: 804-807.
15. Monteleone P, Di Lieto A, Tortorella A, Longobardi N, Maj M. Circulating leptin in patients with anorexia nervosa, bulimia nervosa or binge-eating disorder: relationship to body weight, eating patterns, psychopathology and endocrine changes. Psychiatry Res 2000; 15: 121-129.
16. Warren MP, Voussonghian F, Geer EB, Hyle EP, Adberg CL, Ramos RH. Functional hypothalamic amenorrhea: hypoleptinemia and disordered eating. J Clin Endocrinol Metab 1999; 84: 873-877.
17. Argente J, Barrios V, Chowen JA, Sinha MK, Considine RV. Leptin plasina levels in healthy Spanish children and adolescents with obesity and adolescents with anorexia nervosa and bulimia nervosa. J Pediatr 1997; 131: 833-838.
18. García-Patterson A, Muñoz MT, Puig-Domingo M, Argente J, Webb SM. Urine 6-sulphatoxymelatonin excretion during anorexia nervosa treatment. In: Webb S, Puig-Domingo M, Moller M, Pevet P, eds. Panel Update: From Molecular Biology to Clinical Medicine. Westbury, NY: PJD Electronic Publications Editorial, 1997; 255-262.
19. Golden N, Jacobson MS, Schebendach J, Solanto MV, Hertz SM, Shenker R. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med 1997; 151: 16-21.
20. De Marinis L, Mancini A, Valle D, Bianchi A, Gentilella R, Milardi D, Mascadri C, Giustina A. Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa. Metabolism 2000; 49: 155-159.
21. Nussbaum MP, Blethen SL, Chasalow FI, Jacobson MS, Shenker IR, Feldman J. Blunted growth hormone responses to clonidine in adolescent girls with early anorexia nervosa. Evidence for an early hypothalamic defect. J Adolesc Health Care 1990; 11: 145-148.
22. Argente J, Caballo N, Barrios V, Muñoz MT, Pozo J, Chowen JA, Morandé G, Hernández M. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation. J Clin Endocrinol Metab 1997; 82: 2084-2092.
23. Hochberg Z, Hertz P, Colin V, Ish-Shalom S, Yeshurun D, Youdim MBH, Amit T. The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa. Metabolism 1992; 41: 106-112.
24. Counts DR, Gwirtsman H, Carlsson LMS, Lesem M, Cutler GB Jr. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab 1992; 75: 762-767.
25. Argente J, Muñoz MT, Pozo J, Barrios V, Buño M, Chowen JA, Hernández M. Growth hormone resistance in anorexia nervosa as a model of malnutrition. J Endocrinol Invest 1998; 21: 24-28.
26. Zamboni G, Dufillot D, Antoniazzi F, Valentini R, Gendrel D, Tatò L. Growth hormone binding proteins and insulin-like growth factor-binding proteins in protein-energy malnutrition, before and after nutritional rehabilitation. Pediatr Res 1996; 39: 410-414.
27. Roelen CAM, Koppeschaar HPF, De Vries WR, Snel YEM, Doerga ME, Zelissen PMJ, Thijssen JH, Blankenstein MA. Visceral adipose tissue is associated with circulating high affinity growth hormone binding protein. J Clin Endocrinol Metab 1997; 82: 760-764.
28. Golden NH, Kreitzer P, Jacobson MS, Chasalow FI, Schebendach J, Freedman SM, Shenker IR. Disturbances in growth hormone secretion and action in adolescents with anorexia nervosa. J Pediatr 1994; 125: 655-660.
29. Ketelslegers JM, Maiter D, Maes M, Underwood LE, Thissen JP. Nutritional regulation of insulin-like growth factor I. Metabolism 1995; 44 (Suppl 4): 50-57.
30. Hernández M, Argente J, Navarro A, Caballo N, Barrios V, Hervás F, Polanco I. Growth in malnutrition related to gastrointestinal diseases: coeliac disease. Horm Res 1992; 38: 79-84.
31. Støving RK, Flyvbjerg A, Frystyc J, Fisker S, Hangaard J, Hansen-Nord M, Hagen C. Low serum levels of free and total insulin-like growth factor I (IFG-I) in patients with anorexia nervosa are not associated with increased IGF-binding protein-3 proteolysis J Clin Endocrinol Metab 1999; 84: 1346-1350.
32. Straus DS, Hayden JM, Marten NW. Molecular mechanisms for nutritional regulation of genes for IGF-I, IGF-binding proteins and other plasma proteins. In: Baxter RC, Gluckman PD, Rosenfeld RG, eds. The Insulin-like Growth Factors and their Regulatory Proteins. Amsterdam: Elsevier Science B.V., 1994; 33-41.
33. Rajaram, S, Baylink DJ, Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 1997; 18: 801-831.
34. Argente J, Barrios V, Chowen JA, Muñoz MT, Pozo J, Hernández M. Insuhn-like growth factor binding protein (IGFBP) 4 and 5 levels in patients with anorexia nervosa. Horm Res 1997; 48 (Suppl 2): 42 (A251).
35. Baker D, Roberts R, Towell T. Factors predictive of bone mineral density in eating-disordered women: a longitudinal study. Int J Eat Disord 2000; 27: 29-35.
36. Muñoz MT, Argente J. Anorexia nervosa in female adolescents: endocrine and bone mineral density abnormalities. Eur J Endocrinol 2002; 147: 275-286.
37. Zipfel S, Seibel MJ, Lowe B, Beumont PJ, Kasperk C, Herzog W. Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa. J Clin Endocrinol Metab 2001; 86: 5227-5233.
38. Zipfel S, Lowe B, Reas DL, Deter HC, Herzog W. Long-term prognosis in anorexia nervosa: lessons from a 21-year follow-up study. Lancet 2000; 355: 721.
39. Muñoz MT, Morandé G, García-Centenera JA, Hervás F, Pozo J, Argente J. The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa. Eur J Endocrinol 2002; 46: 45-50.
40. Klibanski A, Biller BM, Schoenfeld DA, Herzog DB, Saxe VC. The effects of estrogen administration on trabecular bone loss in young women with anorexia nervosa. J Clin Endocrinol Metab 1995; 80: 898-904.
41. Ogueh O, Sooranna S, Nicolaides KH, Johnson MR. Tile relationship between leptin concentrations and bone metabolism in the human fetus. J Clin Endocrinol Metab 2000; 85: 1997-1999.
42. Pasco JA, Henry MJ, Kotowicz MA, Collier GR, Ball MJ, Ugoni AM, Nicholson GC. Serum leptin levels are associated with bone mass in nonobese women J Clin Endocrinol Metab 2001; 86: 1884-1887.
43. Calero JA, Muñoz MT, Argente J, Traba ML, Méndez-Dávila C, García-Moreno C, de la Piedra C. A variation in bone alkaline phosphatase levels that correlates positively with bone loss and normal levels of amino-terminal propeptide of collagen I in girls with anorexia nervosa. Clin Chim Acta 1999; 285: 121-129.
44. De la Piedra C, Calero JA, Traba ML, Asensio MD, Argente J, Muñoz MT. Urinary and C-telopeptides of collagen I: clinical implications in bone remodeling in patients with anorexia nervosa. Osteoporosis Int 1999; 10: 480-486.
45. Hartman D, Crisp A, Rooney B, Rackow C, Atkinson R, Patel S. Bone density of women who have recovered from anorexia nervosa. Int J Eat Disord 2000; 28: 107-112.
46. Grinspoon S, Baum H, Lee K, Anderson E, Herzog D, Klibanski A. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa. J Clin Endocrinol Metab 1996; 81: 3864-3870.
47. Turner JM, Bulsara MK, McDermott BM, Byrne GC, Prince RL, Forbes DA. Predictors of low bone density in young adolescents with anorexia nervosa and other dieting disorders. Int J Eat Disord 2001; 30: 245-251.
48. Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T, Takano K. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. J Clin Endocrinol Metab 2000; 85: 200-206.
49. Johansson AG, Rosen CJ. The IGFs as potential therapy for metabolic bone diseases. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of Bone Biology. San Diego, CA: Academic Press, 1996; 1099-1109.
50. Bianda T, Glatz Y, Bouillon R, Froesch ER, Schmid C. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. J Clin Endocrinol Metab 1998; 83: 81-87.
51. Soyka LA, Grinspoon S, Levitsky L, Herzog D, Klibanski A. The effect of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab 1999; 84: 4489-4496.
52. Jagielska G, Wolanczyk T, Komender J, Tomaszewicz-Libudzic C, Przedlacki J, Ostrowaski K. Bone mineral content and bone mineral density in adolescent girls with anorexia nervosa: a longitudinal study. Acta Psychiatry Scand 2001; 104: 131-137.